Katharina Hauck speaking at the Annual Meeting 2017 of the World Economic Forum in Davos (Copyright by World Economic Forum / Sikarin Thanachaiary)
World AIDS Day takes place annually on 1 December as an opportunity for people worldwide to unite in the fight against HIV and to show support for people living with HIV/AIDS.
To mark World AIDS Day 2017, we have published a series of blog posts to highlight the important and varied research that takes places at Imperial. Three experts from Faculty of Medicine share their interest in HIV/AIDS which spans from the elusive vaccine to the economics of the epidemic.
The role of an economist in the HIV epidemic
As an economist, my research on HIV takes a higher-level population view. We advise policy makers in governments and international organisations on the cost-effectiveness of preventive and treatment interventions in the countries most ravaged by HIV. By estimating the benefits and costs of interventions, we can identify the ones that promise greatest improvements in population health.
The largest community-randomised trial of the universal HIV test and treat strategy
For example, we are currently conducting an economic evaluation of HPTN071/PopART; the largest study on the impact of a package of testing and prevention interventions on new infections in Zambia and South Africa. We measure the benefits of treatment to HIV-infected individuals who are found and diagnosed earlier because of PopART, and we expect that the interventions will also prevent new infections. It’s tricky to estimate exactly how many individuals will be spared from getting infected in future, but we work with epidemiologists who use complex modelling to project the number of prevented infections into the future. (more…)
Imagine you are running a marathon. You have reached the final mile of a long and arduous journey. You turn the last corner expecting to see the finish line, and instead you see a huge vertical ascent. The finish line is waiting at the top, hundreds of metres above you.
Such is the plight of the Global Polio Eradication Initiative. In 1988, the year the initiative was launched, polio paralysed an estimated 350,000 people worldwide – roughly 1,000 each day. Over the last three decades, a globally coordinated vaccination campaign has fought the disease back to a few remaining refuges in Afghanistan, Pakistan, and Nigeria. In 2017, wild poliovirus has caused just 12 cases so far.
As we mark the fifth annual World Polio Day, the finish line of the eradication marathon is firmly in sight, but getting there will be a tough climb.
Why has polio proven so hard to vanquish? First and foremost, the disease’s final strongholds are regions of immense political unrest, and news of deadly attacks against vaccination workers are all too familiar. Every step towards polio’s eradication is one that requires those at the front line to put their lives at risk. (more…)
Today is World Rabies Day. The goal of this global day is enhanced awareness spurring further efforts to prevent rabies, a viral disease that kills tens of thousands of people each year mainly in Asia and Africa. Two years ago, international organisations – including the World Health Organization and the World Organization for Animal Health – agreed to an ambitious, but achievable common goal: to end human deaths due to canine rabies by 2030. In fact, ‘Rabies: Zero by 30’ is the theme of the 2017 World Rabies Day.
Why today? 28 September 2017 is the 122nd anniversary of Louis Pasteur’s death. It was he who developed the first vaccines for both rabies and anthrax. All mammals can become infected with the rabies virus, and rabies is present on every continent except Antarctica. This can sound overwhelming. However, up to 99% of human rabies cases result from human dog bites. So what can be done to keep ‘man’s best friend’ from transmitting this fatal virus? Vaccination! (more…)